Lowest Price Guaranteed
Pages
199
Last Updated
June 2026
View Count
11310
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Introduction
2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative
2.4.2.3. Advantages
2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions
2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Hospitals
2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity
2.4.3. Analytical Tools and Databases
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach
3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)
3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis
3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation
3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Epigenetics
6.2.1. Key Characteristics of Epigenetics
6.2.2. Key Applications of the Epigenetics
6.2.3. Challenges Associated with Epigenetics
6.3. Future Perspective
7. COMPETITIVE LANDSCAPE
7.1. Chapter Overview
7.2. Epigenetics Providers: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Location of Headquarters
7.2.4. Epigenetics: Overall Market Landscape
7.2.4.1. Analysis by Product Type
7.2.4.2. Analysis by Technology Type
7.2.4.3. Analysis by Application Area Type
7.2.4.4. Analysis by End Users
8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodologies
8.4. Company Competitiveness Analysis: Epigenetics Providers
8.4.1. Epigenetics Providers Based in North America (Peer Group 1)
8.4.2. Epigenetics Providers Based in Europe (Peer Group 2)
8.4.3. Epigenetics Providers Based in Asia-Pacific (Peer Group 3)
8.4.4. Epigenetics Providers Based in Middle East and North Africa, and Latin America (Peer Group 4)
8.5. Key Findings
9. COMPANY PROFILES
9.1. Chapter Overview
9.2. 10x Genomics
9.2.1. Company Overview
9.2.2. Financial Information
9.2.3. Service / Product Portfolio
9.2.4. Recent Developments and Future Outlook
* Similar details are presented for other below mentioned companies based on information in the public domain
9.3. Active Motif
9.4. Bio-Rad Laboratories
9.5. Dovetail Genomics
9.6. Element Biosciences
9.7. Illumina
9.8. Merck
9.9. New England Biolabs
9.10. Novartis
9.11. PerkinElmer
9.12. Promega
9.13. Pacific Biosciences of California
9.14. Storm Therapeutics
9.15. QIAGEN
9.16. Thermo Fisher Scientific
9.17. Zymo Research
10. SWOT ANALYSIS
11. MARKET IMPACT ANALYSIS
11.1. Chapter Overview
11.2. Market Drivers
11.3. Market Restraints
11.4. Market Opportunities
11.5. Market Challenges
11.6. Conclusion
12. GLOBAL EPIGENETICS MARKET
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Trends Disruption Impacting Market
12.4. Global Epigenetics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
12.5. Multivariate Scenario Analysis
12.5.1. Conservative Scenario
12.5.2. Optimistic Scenario
12.6. Key Market Segmentations
13. MARKET OPPORTUNITIES BASED ON TYPE OF PRODUCT
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Revenue Shift Analysis
13.4. Market Movement Analysis
13.5. Penetration-Growth (P-G) Matrix
13.6. Epigenetics Market for Reagents: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7. Epigenetics Market for Kits: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7.1. Epigenetics Market for ChIP Sequencing Kit: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7.2. Epigenetics Market for Whole Genomic Amplification Kit: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7.3. Epigenetics Market for Bisulfite Conversion Kit: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7.4. Epigenetics Market for RNA Sequencing Kit: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7.5. Epigenetics Market for Others: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.8. Epigenetics Market for Instruments: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.9. Epigenetics Market for Enzymes: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.10. Epigenetics Market for Services: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.11. Data Triangulation and Validation
14. MARKET OPPORTUNITIES BASED ON TYPE OF TECHNOLOGY
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Revenue Shift Analysis
14.4. Market Movement Analysis
14.5. Penetration-Growth (P-G) Matrix
14.6. Epigenetics Market for DNA Methylation: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.7. Epigenetics Market for Histone Methylation: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.8. Epigenetics Market for Histone Acetylation: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.9. Epigenetics Market for Large Non-Coding RNA: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.10. Epigenetics Market for Microrna Modification: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.11. Epigenetics Market for Chromatin Structures: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.12. Data Triangulation and Validation
15. MARKET OPPORTUNITIES BASED ON APPLICATION AREA
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Revenue Shift Analysis
15.4. Market Movement Analysis
15.5. Penetration-Growth (P-G) Matrix
15.6. Epigenetics Market for Oncology: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.6.1. Epigenetics Market for Solid Tumors: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.6.2. Epigenetics Market for Liquid Tumors: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.7. Epigenetics Market for Non-Oncology: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.7.1. Epigenetics Market for Inflammatory Diseases: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.7.2. Epigenetics Market for Metabolic Diseases: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.7.3. Epigenetics Market for Infectious Diseases: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.7.4. Epigenetics Market for Cardiovascular Diseases: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.7.5. Epigenetics Market for Others: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.8. Data Triangulation and Validation
16. MARKET OPPORTUNITIES BASED ON TYPE OF END USER
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Revenue Shift Analysis
16.4. Market Movement Analysis
16.5. Penetration-Growth (P-G) Matrix
16.6. Epigenetics Market for Academic Research: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.7. Epigenetics Market for Clinical Research: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.8. Epigenetics Market for Hospitals & Clinics: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.9. Epigenetics Market for Pharmaceutical & Biotechnology Companies: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.10. Epigenetics Market for Other End Users: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.11. Data Triangulation and Validation
17. MARKET OPPORTUNITIES FOR EPIGENETICS IN NORTH AMERICA
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Revenue Shift Analysis
17.4. Market Movement Analysis
17.5. Penetration-Growth (P-G) Matrix
17.6. Epigenetics Market in North America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.6.1. Epigenetics Market in the US: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.6.2. Epigenetics Market in Canada: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.6.3. Epigenetics Market in Mexico: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.7. Data Triangulation and Validation
18. MARKET OPPORTUNITIES FOR EPIGENETICS IN EUROPE
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix
18.6. Epigenetics Market in Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.6.1. Epigenetics Market in Germany: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.6.2. Epigenetics Market in France: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.6.3. Epigenetics Market in Italy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.6.4. Epigenetics Market in Spain: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.6.5. Epigenetics Market in the UK: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.6.6. Epigenetics Market in Rest of Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.7. Data Triangulation and Validation
19. MARKET OPPORTUNITIES FOR EPIGENETICS IN ASIA-PACIFIC
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix
19.6. Epigenetics Market in Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.1. Epigenetics Market in China: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.2. Epigenetics Market in India: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.3. Epigenetics Market in Japan: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.4. Epigenetics Market in South Korea: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.5. Epigenetics Market in Rest of the Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.7. Data Triangulation and Validation
20. MARKET OPPORTUNITIES FOR EPIGENETICS IN MIDDLE EAST AND NORTH AFRICA (MENA)
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix
20.6. Epigenetics Market in Middle East and North Africa (MENA): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.6.1. Epigenetics Market in Egypt: Historical Trends (Since 2020) and Forecasted Estimates (Till 205)
20.6.2. Epigenetics Market in Saudi Arabia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.6.3. Epigenetics Market in United Arab Emirates (UAE): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.7. Data Triangulation and Validation
21. MARKET OPPORTUNITIES FOR EPIGENETICS IN LATIN AMERICA
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Revenue Shift Analysis
21.4. Market Movement Analysis
21.5. Penetration-Growth (P-G) Matrix
21.6. Epigenetics Market in Latin America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.1. Epigenetics Market in Argentina: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.2. Epigenetics Market in Brazil: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.7. Data Triangulation and Validation
22. APPENDIX 1: TABULATED DATA
23. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
24. CUSTOMIZATION OPPORTUNITIES
25. ROOTS SUBSCRIPTION SERVICES
26. AUTHOR DETAIL